Introduction: We evaluated the radiopacity and antibacterial properties of various concentrations of double antibiotic paste (DAP) containing barium sulfate (BaSO 4 ) or zirconium oxide (ZrO 2 ) radiopaque agents. Methods: The radiopacity of 1, 10, and 25 mg/mL DAP containing 30% (w/v) BaSO 4 or ZrO 2 , DAP-free radiopaque pastes, and commercially available radiopaque calcium hydroxide (Ca [OH] 2 ) were evaluated according to ISO 6876/ 2001 with slight modifications (n = 6 per group). Dentin samples (n = 70) infected anaerobically for 3 weeks with bacterial biofilms obtained from a root canal of an immature tooth with pulpal necrosis were treated with similar experimental pastes or received no treatment (n = 7). After 1 week, the pastes were rinsed off, and biofilm disruption assays were conducted. To show the residual antibacterial effects, sterile dentin samples (n = 70) were pretreated for 1 week with the same pastes (n = 7). The pastes were rinsed off, and the samples were immersed in phosphate-buffered saline for 24 hours and infected anaerobically with the same bacterial biofilm mentioned earlier for 3 weeks before conducting biofilm disruption assays. Sterile dentin blocks were used in both antibacterial analyses as negative control groups (n = 7). Wilcoxon rank sum tests were used for statistical analyses. Results: No tested concentrations of BaSO 4 DAP or ZrO 2 DAP showed significant differences from Ca(OH) 2 in radiopacity. However, all tested concentrations of BaSO 4 DAP, ZrO 2 DAP, and Ca(OH) 2 exhibited significant direct antibacterial effects. ZrO 2 DAP at 1 mg/mL and Ca(OH) 2 did not show significant residual antibacterial effects. Conclusions: BaSO 4 DAP at 1 mg/mL provided significantly superior residual antibacterial effects and comparable radiopacity with the commercially available Ca(OH) 2 . (J Endod 2018;44:1376-1380 
T he introduction of endodontic regeneration procedures has rejuvenated the use of various antibiotic mixtures as intracanal medicaments. Recent in vitro studies have found that intracanal antibiotic medicaments such as triple or double antibiotic paste (DAP) may offer superior root canal disinfection in comparison with traditional calcium hydroxide (Ca [OH] 2 ) intracanal medicament (1, 2) . However, unlike Ca(OH) 2 , clinically used concentrations (500-1000 mg/mL) of these antibiotic mixtures were found to exert cytotoxic effects on stem cells from apical papillae (3, 4) , dental pulp stem cells (5) , and dental pulp fibroblasts (6) . Therefore, evidence-based recommendations suggested the use of Ca(OH) 2 or low concentrations of DAP or triple antibiotic paste ranging between 0.1-1 mg/mL in an attempt to provide an efficient antimicrobial medicament without jeopardizing the fate of pluripotent stem cells within the root canal system (7) .
The inability of these antibiotic medicaments to be visualized radiographically may offer a challenging aspect to clinicians in terms of insuring satisfactory application of the medicaments. Indeed, the use of radiopaque intracanal medicaments can be of particular importance during endodontic regeneration because of the presence of large blunderbuss apices of immature teeth with necrotic pulps. Therefore, over-or underapplication of nonradiopaque antibiotic medicaments can easily go unnoticed, which may lead to suboptimal root canal disinfection during regenerative endodontics. Radiopaque components are usually added to endodontic materials (cements, pastes, sealers, and obturating materials) to provide radiopacity that can help in determining the exact location of the root canal material in the root canal system as well as improving the ability of the material to localize anatomic structures within the root canal system. The radiocontrast agents commonly used in endodontic materials are insoluble salts of heavy metals such as barium, zirconium, and bismuth. The aim of this study was to introduce 2 types of radiopaque DAPs and to investigate the direct and residual antibacterial effects of these radiopaque antibiotic medicaments.
Materials and Methods

Preparation of Radiopaque DAP
Two radiopaque materials, barium sulfate (BaSO 4 ) and zirconium oxide (ZrO 2 ), were selected for this study. Various concentrations of DAP containing the 2 radiopaque agents were prepared as described in previous studies (8, 9) with a modification to incorporate the radiopaque materials. In summary, 10, 100, and 250 mg of equal portions of metronidazole and ciprofloxacin (Champs Pharmacy, San Antonio, TX) were independently dissolved in 10 mL sterile water to form 1-, 10-, and 25-mg/mL DAP solutions, respectively. Then, 3 g barium sulfate (Reagent Plus; Sigma-Aldrich, St Louis, MO) or zirconium oxide (5 mm powder, Sigma-Aldrich) was gradually incorporated into each DAP solution with vigorous stirring to form a 30% radiopaque DAP slurry composed of 30% (w/v) of each radiopaque material. Thereafter, 0.7 g methylcellulose powder (Methocel 60 HG, SigmaAldrich) was gradually dissolved into each DAP slurry at room temperature to create a pasty consistency of DAP. Finally, each radiopaque DAP was centrifuged for 15 minutes at 7000 rpm to form a bubble-free homogenous injectable paste with 1, 10, and 25 mg/mL DAP (BaSO 4 DAP or ZrO 2 DAP). Furthermore, DAP-free radiopaque placebo pastes were also prepared as described previously. The percentage of radiopaque agents (30% w/v) was selected based on pilot studies that examined 20%-40% of both radiopaque agents in 5% increments compared with a commercially available radiopaque Ca(OH) 2 intracanal medicament (UltraCal XS; Ultradent, South Jordan, UT).
Assessment of Radiopacity
The radiopacity of various concentrations of BaSO 4 DAP (1, 10, and 25 mg/mL), ZrO 2 DAP (1, 10, and 25 mg/mL), the 2 DAP-free placebo pastes, and the commercially available radiopaque Ca(OH) 2 medicament (UltraCal XS) were evaluated according to ISO 6876:2012 (10) with slight modifications. Briefly, disk-shaped plastic molds (with an internal diameter of 10 and 1 mm in thickness) were positioned on occlusal radiograph films (Insight-Kodak Comp, Rochester, NY) and filled with the tested pastes (n = 6). Radiographs of the pastes along with an aluminum step wedge with variable thickness (from 1-5 mm in 1-mm increments) were taken using a single-phase dental X-ray unit (Heliodent DS; Sirona Dental, Inc, Charlotte, NC) with 65 kV and a distance of 30 cm. The radiographic films were processed using an automatic processor. Finally, the densities of the image of the pastes were compared with that of the different thickness of the aluminum step wedge using a densitometer (X-Rite model 301; X-Rite, Grand Rapids, MI), and the radiopacity equivalent of each sample was expressed in millimeters of aluminum.
Dentin Sample Preparation
Extracted intact human teeth were used to prepare radicular dentin samples (4 Â 4 Â 2 mm
3 ) according to a standardized protocol. Briefly, a low-speed diamond saw under constant water irrigation was used to obtain dentin samples with the standardized dimensions. The samples were polished sequentially using abrasive papers (500-2400 grit; Struers, Cleveland, OH) and a Roto Pol 31 polishing unit (Struers). The samples were sequentially irrigated with 1.5% sodium hypochlorite, double distilled water, and 17% EDTA (4 minutes each) to open dentin tubules and remove the smear layer (11) . All samples were gas sterilized using ethylene oxide and maintained at 100% humidity and 4 C until they were used.
Collection of Bacterial Isolate
Institutional review board approval was obtained (#1510640949) to collect a clinical bacterial isolate from an infected root canal of an immature tooth that was indicated for endodontic regenerative treatment. The selected subject was healthy and had not used antibiotics for 6 months. Both the subject and his parent signed an informed assent and consent form before collection of the bacterial isolate. The bacterial isolate was obtained according to a standardized protocol detailed in previous studies (2, 12) , anaerobically incubated in brain-heart infusion broth supplemented with 5 g/L yeast extract (BHI-YE) at 37 C for 48 hours, and frozen at À80 C until use.
Direct Antibacterial Effects of Radiopaque DAP Sterile dentin samples (n = 70) were individually inserted into wells of sterile 96-well microtiter plates (FisherBrand Fischer Scientific, Pittsburgh, PA) with the pulpal sides oriented outward. The dentin samples were infected with 10 mL of an overnight culture (1 Â 10 5 colony-forming unit [CFU]/mL) of the biofilm bacteria obtained from an immature tooth with pulpal necrosis, and 190 mL fresh BHI-YE was added. The infected dentin samples were incubated for 3 weeks anaerobically with weekly replacement of the BHI-YE growth media. The weekly replacement of the growth media was aimed to maintain the original taxa of the clinical isolates by limiting the nutritional supply as recommended in previous publications (13, 14) . Three additional dentin samples were infected with the same biofilm bacteria and viewed under scanning electron microscopy (7800F; JEOL, Peabody, MA).
After 3 weeks, the infected dentin samples were randomized into 10 experimental groups (n = 7) and treated for 1 week at 37 C with BaSO 4 DAP (1, 10, and 25 mg/mL), ZrO 2 DAP (1, 10, and 25 mg/mL), BaSO 4 placebo, ZrO 2 placebo, Ca(OH) 2 (UltraCal XS), or sterile water. All infected dentin samples were treated for 1 week at 37 C and 100% humidity. A bacteria-free sterile dentin group (n = 7) was also used in this experiment as a negative control group to exclude the presence of bacterial contamination though the course of the experiment. The dentin samples in the negative control group received fresh BHI-YE and were incubated anaerobically with the rest of the samples for 3 weeks with weekly replacement of BHI-YE.
After treatment, each sample was gently irrigated with 3 mL sterile water for 1 minute to rinse off the treatment pastes, and each dentin sample was subjected to a biofilm disruption assay as described in earlier studies (15, 16) . Briefly, each dentin sample was placed into a sterile test tube containing 2 mL sterile water. Each sample was sonicated and vortexed (30 seconds each) to dislodge the biofilms. The obtained biofilms were diluted, spiral plated on blood agar plates, and incubated anaerobically for 24 hours; CFU/mL was counted using an automated colony counter (Synbiosis, Inc, Frederick, MD).
Residual Antibacterial Effects of Radiopaque DAP
Additional sterilized dentin samples (n = 70) were placed in 96-well microtiter plates in order to be pretreated for 1 week with the same 10 experimental groups described previously. After treatment, the pastes were washed off from the dentin samples using sterile saline followed by a 1-minute irrigation with 5 mL 17% EDTA. Dentin samples were independently immersed in 200 mL sterile phosphate-buffered saline and stored at 37 C for 24 hours. After immersion, dentin samples were infected with an overnight culture of the biofilm bacteria obtained from the immature tooth with pulpal necrosis as discussed earlier (n = 7). The bacterial biofilms were grown anaerobically for 3 weeks as described earlier. Additional noninfected sterile dentin samples (n = 7) were used as a negative control throughout this experiment.
After the incubation period, all samples were subjected to biofilm disruption assays, and CFU/mL was quantified.
Statistical Analyses
Wilcoxon rank sum tests were used to compare the radiopacity, direct, and residual antibacterial effects of all experimental groups (a = 0.05).
Results
Assessment of Radiopacity
Both BaSO 4 DAP and ZrO 2 DAP at the 3 tested concentrations (1, 10, and 25 mg/mL) did not show a significant difference from Ca(OH) 2 (the commercial control) in radiopacity (Fig. 1) . However, the ZrO 2 placebo samples showed significantly higher radiopacity (P < .01) than BaSO 4 DAP (all concentrations), Ca(OH) 2 , and ZrO 2 DAP at 25 mg/mL. ZrO 2 DAP at 1, 10, and 25 mg/mL exhibited significantly higher radiopacity than BaSO 4 DAP at 1, 10, and 25 mg/mL, respectively (P < .01).
Assessment of Direct Antibacterial Effects
BaSO 4 DAP and ZrO 2 DAP at the 3 tested concentrations (1, 10, and 25 mg/mL) and Ca(OH) 2 showed significant direct antibacterial effects in comparison with placebo pastes and the no treatment control groups (P < .001) ( Table 1) . Furthermore, BaSO 4 DAP at all tested concentrations and ZrO 2 DAP at 10 and 25 mg/mL showed significantly higher antibacterial effects in comparison with ZrO 2 DAP at 1 mg/mL (P < .01). No bacterial growth was detected in the negative (sterile) control group. Scanning electron microscopic images taken at various magnifications showed thick heterogenic biofilm structures covering most of the pulpal surface of the dentin ( Fig. 2A and B) .
Assessment of Residual Antibacterial Effects
BaSO 4 DAP at all tested concentrations and ZrO 2 DAP at 10 and 25 mg/mL showed significantly higher residual antibacterial effects in comparison with ZrO 2 DAP at 1 mg/mL, Ca(OH) 2 , the placebo pastes, and the no treatment control groups (P < .01) ( Table 1) . However, no significant differences were found among ZrO 2 DAP at 1 mg/mL, Ca(OH) 2 , the placebo pastes, and the no treatment control groups. Additionally, the negative (sterile) control group did not show any bacterial growth.
Discussion
Commercial antibiotic intracanal medicaments such as Ledermix and Odontopaste are available. However, these medicaments contain relatively high concentrations of antibiotic and are not radiopaque, which limits their use. Recent studies introduced an injectable controlled low concentration of DAP loaded into a biocompatible hydrogel (2, 15) . However, one of the limitations of these injectable medications is their lack of radiopaque properties. Because there is no ISO standard for testing intracanal medicaments, the radiopacity testing protocol used in the current study was adapted from the ISO 6876:2012 standards designed for dental root canal sealing materials with a slight modification. The tested medicaments in our study were radiographed immediately after their application into the plastic molds rather than waiting for 24 hours as recommended by ISO because these medicaments are not expected to set like root canal sealers.
The current study introduced 2 different types of radiopaque DAP with controlled concentrations using Food and Drug Administrationapproved radiocontrast agents (BaSO 4 and ZrO 2 ). BaSO 4 is a commonly used radiopaque material in Ca(OH) 2 -based root canal medicaments and zinc oxide-eugenol-based root canal sealers. ZrO 2 is also a Figure 1 . The radiopacity of different radiopaque antibacterial medicaments represented as the mean (AEstandard error) of millimeters of aluminum. Different uppercase letters indicate significant differences between the different types of medicaments.
commonly used radiopaque agent in commercially available bioceramic root canal sealers/cements such as EndoSequence BC Sealer and Biodentine. Furthermore, both radiopaque materials were suggested to be biocompatible (17, 18) with minimum discoloration potential (19, 20) . The current study showed that both ZrO 2 DAP and BaSO 4 DAP at all tested concentrations did not significantly differ from Ca(OH) 2 (UltraCal XS) in radiopacity. However, the tested concentrations of ZrO 2 DAP (1, 10, and 25 mg/mL) showed significantly higher radiopacity than the similarly tested concentrations of BaSO 4 DAP. The commercially available radiopaque Ca(OH) 2 was used in this study because it is one of the most commonly used intracanal medicaments in the United States and has been used in multiple endodontic regeneration studies (3, 4, 9) .
Our study showed that ZrO 2 DAP and BaSO 4 DAP as low as 1 mg/mL caused significant reduction in bacterial biofilm in comparison with the radiopaque DAP-free placebo pastes. This indicates that the addition of these radiopaque agents at 30% (w/v) did not interfere with the direct antibacterial properties of DAP at the tested concentrations (1-25 mg/mL). This agreed with recent studies that found significant direct antibacterial effects of 1 mg/mL nonradiopaque DAP against bacterial biofilm obtained from clinical isolates (2) as well as bacterial biofilm of Enterococcus faecalis (15) . Our study also showed that BaSO 4 DAP at 1 mg/mL exhibited significantly higher direct antibacterial effects than ZrO 2 DAP at 1 mg/mL. It is worth noting that 1 mg/mL DAP was selected in this study as the minimum tested concentration because it is the currently recommended concentration of intracanal antibiotic medicaments for endodontic regeneration (7) .
Our study also found that BaSO 4 DAP at 1 mg/mL exhibited significant residual antibacterial effects. On the other hand, ZrO 2 DAP at 1 mg/mL as well as Ca(OH) 2 did not exhibit any significant residual antibacterial effects. This might suggest that ZrO 2 can interfere with the residual antibacterial effects of 1 mg/mL DAP. Therefore, a higher concentration of DAP may be needed if ZrO 2 is to be used as a radiopaque agent because ZrO 2 DAP at 10 mg/mL showed significant residual antibacterial effects. The collective finding of direct and residual antibacterial experiments conducted in this study indicates that BaSO 4 DAP exhibited significantly superior antibacterial properties compared to ZrO 2 DAP at 1 mg/mL. One of the main advantages of using antibiotic-containing intracanal medicaments over Ca(OH) 2 during regenerative endodontics is the residual ability of these antibiotics to bind to dentin matrix and extend the antimicrobial properties within the root canal system even after their removal (1, 2) . Recent in vitro studies, as in this study, have found that Ca(OH) 2 cannot provide any residual antibacterial properties after its removal from radicular dentin (1, 2) . These laboratory findings are in support of clinical studies that found bacterial regrowth after the removal of a Ca(OH) 2 intracanal medicament (21, 22) . Radiopaque DAP in concentrations higher than the range recommended by the American Association of Endodontists (0.1-1 mg/mL) was also tested in this study because current evidence suggested that 1 mg/mL of antibiotic combinations may not be enough to eradicate bacterial biofilm (23) . Indeed, a recent study suggested that the residual bacterial biofilms and their byproducts altered the osteogenic differentiation of stem cells from apical papillae (24) . In the current study, a clinical isolate obtained from an immature tooth with necrotic pulp was used to establish the bacterial biofilm in an attempt to create a more resistant in vitro model. Bacterial biofilms from immature teeth were found to be more resistant to antimicrobials compared with bacterial biofilms from mature teeth (2, 25) . Collectively, our study indicates that BaSO 4 DAP at 1 mg/mL offered significantly superior residual antibacterial properties and comparable radiopacity with the commercially available radiopaque Ca(OH) 2 medicament. Additionally, ZrO 2 DAP at 1 mg/mL showed comparable radiopacity and antibacterial characteristics. Further studies are warranted to determine the biocompatibility of the suggested radiopaque DAP medicaments.
